MOPP

MOPP is a combination of intravenous anti-cancer drugs consisting of mustine (nitrogen mustard), vincristine (Oncovin), procarbazine and prednisolone. It is used in the treatment of advanced non-Hodgkin lymphoma. Its side-effects may be reduced by the use of the growth factors granulocyte macrophage colony stimulating factor (GM-CSF) or granulocyte colony stimulating factor (G-CSF).

Up a level
Back to contents
This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.